Evaluate provides a view of the pharmaceutical market through solutions that combine technology, real world data, and analytics to assist in making portfolio decisions in the biopharma industry.

Evaluate

Evaluate Pharma & Evaluate Omnium

Evaluate Medtech

EvaluateCustomSolutions

Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. 

Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:

Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.

EvaluatePharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma 
 
EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.

Evaluate Custom Solutions -  improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence. 

Explore Evaluate at  www.evaluate.com
Twitter: @EvaluatePharma




Advera Health Analytics

Mercury

Evaluate Ltd

As we launched into 2024, hopes were moderately high for dealmaking and investment in #pharma. What was the score at the halfway point in the year? Our new eBook digs into the detail behind the headline figures of a very bumpy recovery. https://ow.ly/LsAt50STztr

What’s the secret formula for creating the next #pharmaceutical behemoth? https://ow.ly/oJL150SPSXJ

Download Evaluate's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

Missed our webinar about #AI in #pharma forecasting? Fear not, we have a blog post with a few highlights for you. And the webinar featuring J+D Forecasting is available on-demand! https://ow.ly/m8Eq50SSYHR

Screening and valuing #pharma assets can be a thorny path, with so many data points to work through. Evaluate Ltd's solutions provide an accurate, impartial, and timely view of pharma #asset potential. Find out more: https://lnkd.in/eseaFYEz

Missed this? Now's the time to catch up on the latest #pharma forecasts with our World Preview #report. Download the full report here: https://lnkd.in/gMe5hqD7

What’s the secret formula for creating the next #pharmaceutical behemoth? https://lnkd.in/gCusCD2U

Download Evaluate Ltd's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

EVAL

COM:EVALUATE

Evaluate